HEMO+
LIVE

Serial Number

79286967

Owner

HEMO PLUS S?rl

Attorney

Duane M. Byers

Filing Date

Dec 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HEMO+ Trademark

Serial Number: 79286967 • Registration: 6344136

HEMO+ is a trademark filed by HEMO PLUS S?rl on December 20, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 6 (Metal Goods), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 11 (Environmental Control), Class 37 (Building & Construction), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HEMO PLUS S?rl

Rue du Lion-d'Or 1

Entity Type: 99

Trademark Details

Filing Date

December 20, 2019

Registration Date

May 11, 2021

Published for Opposition

February 23, 2021

Goods & Services

Data processing equipment and computers for use in the medical field; data processing equipment and data processing machines for use in the medical field

Educational and training services, namely providing classes, seminars, workshops, teaching, and distance learning in the medical fields, namely in the field of hemodialysis; vocational retraining in the medical field; personalized coaching as a training service and as an educational service in the medical field; information relating to education; training for staff development, team building and organizational development in the medical field

Installation, maintenance and repair of installations, equipment and apparatus in the medical field, namely, Hemodialysis machines, control instruments and apparatus in the medical field, namely, controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus, measuring or testing instruments and machines in the medical field, namely, wearable monitors used to measure biometric data for medical use, and blood testing apparatus; installation of clean room systems

Prefabricated buildings of metal and prefabricated modular metal structures for creating premises for installation of manufacturing units for drugs, concentrated products for hemodialysis treatment and care premises for hemodialysis treatment provided to patients suffering from kidney disorders

Technical scientific research and manufacturing project studies in the medical field; technical scientific research and manufacturing project studies and scientific research projects in the medical field; technical scientific research and manufacturing project planning; quality control of products and services in the medical field

Hemodialysis machines; control instruments and apparatus in the medical field, namely, controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; measuring or testing instruments and machines in the medical field, namely, wearable monitors used to measure biometric data for medical use, and blood testing apparatus

Waste disposal incinerators; clean rooms; clean-room installations; apparatus and machines for purifying air and water in the medical field; devices for cooling air and water in the medical field, namely, water coolers, evaporative air coolers, and air conditioning apparatus

Concentrated pharmaceutical products for hemodialysis treatment, packaged in drums and containers, and diluted products for hemodialysis treatment; pharmaceutical products for hemodialysis and other treatments packaged in flexible bags or glass ampoules, especially solid solutes such as glucose for rehydration and calorie intake; glycocol as a solution for irrigation of blood; mannitol as a solution for irrigation of blood; pharmaceutical preparation, namely, glucose/NaCl mix, for rehydration; pharmaceutical preparation, namely, Ringer's lactate solution for hydroelectric rebalance, hypovolemia, maintaining acid-base balance; pharmaceutical preparation, namely, sodium chloride for rehydration and hydroelectric rebalance, water for injection (WFI) for injectable preparations in the nature of irrigation solution for irrigation of blood; pharmaceutical preparation, namely, generic medical preparations, in the nature of ciprofloxacin as an antibiotic; pharmaceutical preparation, namely, fluconazole as an antifungal, ketoprofen as an analgesic and anti-inflammatory; pharmaceutical preparation, namely, levobupivacaine as an anesthetic; pharmaceutical preparation, namely, levofloxacin as an antibiotic; pharmaceutical preparation, namely, metronidazole as an antibiotic and antiparasitic; pharmaceutical preparation, namely, morphine hydrochloride as an analgesic; pharmaceutical preparation, namely, moxifloxacin as an antibiotic; pharmaceutical preparation, namely, ofloxacin as an antibiotic; pharmaceutical preparation, namely, paracetamol as an analgesic and antipyretic, ropivacaine Hcl as an anaesthetic; pharmaceutical preparation, namely, tirofiban as an anticoagulant; pharmaceutical preparation, namely, zoledronic acid for patients suffering from osteoporosis; pharmaceutical preparation, namely, injectable ampoules containing medicated preparations, namely, quinine as an antimalarial, potassium chloride for hypokalemia, hydroelectric rebalancing; pharmaceutical preparation, namely, sodium chloride for hydroelectric rebalancing; pharmaceutical preparation, namely, water for injection (WFI) as a vehicle for parenteral administration; pharmaceutical preparation, namely, magnesium sulfate for hypokalemia, eclampsia, torsade de pointe, hypocalcemia; pharmaceutical preparation, namely, sodium bicarbonate for metabolic acidosis, cardiovascular arrest; pharmaceutical preparation, namely, glucose for carbohydrate calorie intake

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 11, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 13, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 17, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 28, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 27, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 11, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 11, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 3, 2021 NONP
ASSIGNED TO LIE
Jan 19, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 19, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 19, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 19, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 19, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2021 TROA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 20, 2020 CORN
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 9, 2020 ADCH
REFUSAL PROCESSED BY IB
Aug 1, 2020 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 24, 2020 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 15, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jul 15, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Jun 12, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 4, 2020 REPR